Literature DB >> 18501513

Cholinergic modulation of neural activity in the telencephalon of the zebrafish.

Eunjin Park1, Yunkyung Lee, Yongjung Kim, Chang-Joong Lee.   

Abstract

In this study, we have assessed the effects of muscarinic receptor activation on neural activity in the telencephalon of the zebrafish. Electrically evoked field potentials via the stimulation of the posterior dorsal telencephalon were recorded in the anterior dorsal telencephalon of the ipsilateral hemisphere, with a peak latency of 20-30ms. The application of carbachol (1-25microM) and oxotremorine-M (0.25-60microM) suppressed the amplitude of field potentials in a dose-dependent manner. This suppressive effect was blocked by a muscarinic receptor antagonist, atropine (20microM), and an M1 receptor antagonist, pirenzepine (5microM), but not by the M2 receptor antagonists, methoctramine (5microM) and gallamine (5microM). Oxotremorine-M (1microM) also suppressed the induction of field potentials via the stimulation of the contralateral telencephalon and the medial fiber bundle, which was blocked by atropine (20microM). An acetylcholine esterase inhibitor, physostigmine (20-30microM), reduced the peak amplitude of the evoked field potentials, while increasing late bursting activity. Furthermore, a high dose of physostigmine (100microM) induced spontaneous bursting activity. These results demonstrated the cholinergic influence on the neural activity in the telencephalon of the zebrafish.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18501513     DOI: 10.1016/j.neulet.2008.04.064

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

Review 1.  Zebrafish as a Promising Tool for Modeling Neurotoxin-Induced Alzheimer's Disease.

Authors:  Baban S Thawkar; Ginpreet Kaur
Journal:  Neurotox Res       Date:  2021-03-09       Impact factor: 3.911

Review 2.  Zebrafish models in neuropsychopharmacology and CNS drug discovery.

Authors:  Kanza M Khan; Adam D Collier; Darya A Meshalkina; Elana V Kysil; Sergey L Khatsko; Tatyana Kolesnikova; Yury Yu Morzherin; Jason E Warnick; Allan V Kalueff; David J Echevarria
Journal:  Br J Pharmacol       Date:  2017-04-05       Impact factor: 8.739

3.  Iron exposure modifies acetylcholinesterase activity in zebrafish (Danio rerio) tissues: distinct susceptibility of tissues to iron overload.

Authors:  M C B Sant'Anna; Vanessa de Matas Soares; Kelly Juliana Seibt; Gabriele Ghisleni; Eduardo Pacheco Rico; Denis Broock Rosemberg; Jarbas Rodrigues de Oliveira; Nadja Schröder; Carla Denise Bonan; Mauricio Reis Bogo
Journal:  Fish Physiol Biochem       Date:  2010-12-31       Impact factor: 2.794

4.  Can zebrafish be used as animal model to study Alzheimer's disease?

Authors:  Soraya Santana; Eduardo P Rico; Javier S Burgos
Journal:  Am J Neurodegener Dis       Date:  2012-05-15

5.  4-dimensional functional profiling in the convulsant-treated larval zebrafish brain.

Authors:  Matthew J Winter; Dylan Windell; Jeremy Metz; Peter Matthews; Joe Pinion; Jonathan T Brown; Malcolm J Hetheridge; Jonathan S Ball; Stewart F Owen; Will S Redfern; Julian Moger; Andrew D Randall; Charles R Tyler
Journal:  Sci Rep       Date:  2017-07-26       Impact factor: 4.379

6.  Zebrafish: an emerging real-time model system to study Alzheimer's disease and neurospecific drug discovery.

Authors:  Suraiya Saleem; Rajaretinam Rajesh Kannan
Journal:  Cell Death Discov       Date:  2018-10-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.